|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Dundee |
|---|---|
| Information provided by: | University of Dundee |
| ClinicalTrials.gov Identifier: | NCT00486967 |
Purpose
Whether insulin resistance common among Chronic Heart Failure (CHF) patients in Tayside and identify factors associated with insulin resistance in CHF.
We also want to identify mechanism for the impaired exercise capacity and reduced peak VO2 in CHF
| Condition |
|---|
|
Congestive Heart Failure Heart Failure |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Observational Model: Natural History Time Perspective: Cross-Sectional Time Perspective: Prospective |
| Official Title: | Insulin Resistance: A New Target in Heart Failure |
Eligibility| Ages Eligible for Study: | 30 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Matlooba A ALZadjali, BSc, MD, MPH | 0044(0)1382 660111 ext 33176 | m.alzadjali@dundee.ac.uk |
| United Kingdom | |
| University of Dundee | Recruiting |
| Dundee, United Kingdom, DD1 9SY | |
| Contact: James Houston 0044(0)1382384664 j.z.houston@dundee.ac.uk | |
| Sub-Investigator: MATLOOBA A ALZadjali, BSC,MD,MPH | |
| Principal Investigator: | Chim C Lang, MD, FRCP | University of Dundee, Scotland, UK |
More Information
| ClinicalTrials.gov Identifier: | NCT00486967 History of Changes |
| Other Study ID Numbers: | MAT001 |
| Study First Received: | June 13, 2007 |
| Last Updated: | June 13, 2007 |
| Health Authority: | United Kingdom: Research Ethics Committee |
|
Insulin resistance, heart failure, congestive heart failure, Peak VO2, Endothelial Function, Leptin, TNF. |
|
Heart Failure Insulin Resistance Heart Diseases Cardiovascular Diseases Hyperinsulinism Glucose Metabolism Disorders |
Metabolic Diseases Insulin Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |